Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127065731 | 12706573 | 1 | I | 2016 | 20160222 | 20160901 | 20160901 | EXP | US-JNJFOC-20160300033 | PHARMACYCLICS | 71.96 | YR | E | M | Y | 0.00000 | 20160901 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127065731 | 12706573 | 1 | PS | IMBRUVICA | IBRUTINIB | 1 | Oral | N | 205552 | 560 | MG | CAPSULE | QD | ||||||
| 127065731 | 12706573 | 2 | SS | KEPPRA | LEVETIRACETAM | 1 | U | 0 | |||||||||||
| 127065731 | 12706573 | 3 | SS | PLAVIX | CLOPIDOGREL BISULFATE | 1 | 0 | ||||||||||||
| 127065731 | 12706573 | 4 | C | ALBUTEROL. | ALBUTEROL | 1 | 0 | ||||||||||||
| 127065731 | 12706573 | 5 | C | GABAPENTIN. | GABAPENTIN | 1 | 0 | ||||||||||||
| 127065731 | 12706573 | 6 | C | TOPROL XL | METOPROLOL SUCCINATE | 1 | 0 | ||||||||||||
| 127065731 | 12706573 | 7 | C | REMERON | MIRTAZAPINE | 1 | 0 | ||||||||||||
| 127065731 | 12706573 | 8 | C | SINGULAIR | MONTELUKAST SODIUM | 1 | 0 | ||||||||||||
| 127065731 | 12706573 | 9 | C | PRILOSEC | OMEPRAZOLE MAGNESIUM | 1 | 0 | ||||||||||||
| 127065731 | 12706573 | 10 | C | QUETIAPINE. | QUETIAPINE | 1 | 0 | ||||||||||||
| 127065731 | 12706573 | 11 | C | LANTUS | INSULIN GLARGINE | 1 | 0 | ||||||||||||
| 127065731 | 12706573 | 12 | C | TYLENOL | ACETAMINOPHEN | 1 | 0 | UNSPECIFIED | |||||||||||
| 127065731 | 12706573 | 13 | C | CALCIUM | CALCIUM | 1 | 0 | ||||||||||||
| 127065731 | 12706573 | 14 | C | GLUCOSAMINE | GLUCOSAMINE | 1 | 0 | ||||||||||||
| 127065731 | 12706573 | 15 | C | ACYCLOVIR. | ACYCLOVIR | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127065731 | 12706573 | 1 | Mantle cell lymphoma |
| 127065731 | 12706573 | 2 | Seizure |
| 127065731 | 12706573 | 3 | Cerebrovascular accident |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127065731 | 12706573 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127065731 | 12706573 | Anxiety | |
| 127065731 | 12706573 | Fall | |
| 127065731 | 12706573 | Haemarthrosis | |
| 127065731 | 12706573 | Haemorrhage | |
| 127065731 | 12706573 | Haemorrhagic diathesis | |
| 127065731 | 12706573 | Headache | |
| 127065731 | 12706573 | Seizure | |
| 127065731 | 12706573 | Skin atrophy | |
| 127065731 | 12706573 | Wound infection staphylococcal |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127065731 | 12706573 | 1 | 20141104 | 0 | ||
| 127065731 | 12706573 | 2 | 201602 | 0 | ||
| 127065731 | 12706573 | 3 | 1989 | 0 |